Larry Hamann, Global Head, Drug Discovery Sciences at Takeda Pharmaceuticals, shares how the premature death of a parent influenced his leadership style, why optimism is central to his outlook, and the most important thing for early career research team members to accomplish in their first five years with his company
Jason Harcup, Unilever’s Global Vice President for Skin Care Research & Development, explains how his company plans to eliminate carbon emissions from its own operations by 2030. Jason also shares some details on how Unilever develops and retains young talent, and his plans to write a book on the Science and Technology of Skin Care (or not write it – Jason explains)
Robert Reiter, Bayer’s Head of R&D, Crop Science, talks about how collaboration has changed at Bayer in the last year, how Bayer Crop Science is arming farmers with critical data accessible through their smart phones, and the connection between the company’s Carbon Farming Initiative and its commitment to sustainability
Bonnie Charpentier, Senior VP of Regulatory and Compliance at Cytokinetics, Inc., forecasts how clinical trials may change in the wake of the pandemic, argues for more federal R&D research spending, and explains three critical career decisions
Corning’s Christine Heckle, Research Director, Inorganic Materials Research & Asia Research Labs, explains why the company introduced a new material for Apple’s iPhone 12, why she thinks advances in materials science in the next 15 years will eclipse those from the last 15, and how a Wuhan-based Corning factory gave the company some valuable early information on how to manage the pandemic in its other global facilities
Dow’s Global Director of Digitalization, Billy Bardin, explains digitalization in a remarkably clear terms: What it is, why it has the attention of industry leaders, and perhaps most importantly, how it will impact your future
Chuck Crawford, the Chief Innovation Officer at GOJO Industries - which manufactures Purell - discusses how the company has responded to the unprecedented demand for its product, and why the future of hand hygiene will never be the same
Mark Noe, Pfizer’s Vice President of Discovery Sciences, has had a ringside seat as Pfizer, and its partner, BioNTech, developed and rolled-out their COVID-19 vaccine. Mark takes us behind the scenes to help us better understand how the vaccine came to be
.png "Billy B. Bardin, Global Digitalization Director, Dow Inc.")
;void(0);){kind=link}